Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR

146.4  -1.6 (-1.08%)

Fundamental Rating

7

ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. ACT gets an excellent profitability rating and is at the same time showing great financial health properties. ACT is not valued too expensively and it also shows a decent growth rate. These ratings could make ACT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ACT had positive earnings in the past year.
ACT had a positive operating cash flow in the past year.
ACT had positive earnings in each of the past 5 years.
ACT had a positive operating cash flow in 4 of the past 5 years.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

ACT has a better Return On Assets (11.18%) than 98.53% of its industry peers.
ACT has a Return On Equity of 26.31%. This is amongst the best in the industry. ACT outperforms 100.00% of its industry peers.
ACT's Return On Invested Capital of 14.95% is amongst the best of the industry. ACT outperforms 98.53% of its industry peers.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.10%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(14.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROIC 14.95%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACT has a Profit Margin of 9.76%. This is amongst the best in the industry. ACT outperforms 82.35% of its industry peers.
In the last couple of years the Profit Margin of ACT has grown nicely.
The Operating Margin of ACT (14.16%) is better than 80.88% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.27%, ACT belongs to the top of the industry, outperforming 95.59% of the companies in the same industry.
ACT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ACT has an Altman-Z score of 5.60. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT's Altman-Z score of 5.60 is amongst the best of the industry. ACT outperforms 91.18% of its industry peers.
ACT has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
ACT's Debt to FCF ratio of 0.85 is amongst the best of the industry. ACT outperforms 97.06% of its industry peers.
ACT has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, ACT is in the better half of the industry, outperforming 72.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Altman-Z 5.6
ROIC/WACC2.12
WACC7.04%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ACT has a Current Ratio of 2.48. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
ACT has a better Current ratio (2.48) than 77.94% of its industry peers.
ACT has a Quick Ratio of 1.52. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.52, ACT is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.52
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.79%, which is quite impressive.
Measured over the past years, ACT shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.60% on average per year.
Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.59% in the last year.
The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%

3.2 Future

ACT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.19% yearly.
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.33, which means the current valuation is very expensive for ACT.
ACT's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (27.29), we can say ACT is valued inline with the index average.
A Price/Forward Earnings ratio of 22.49 indicates a rather expensive valuation of ACT.
ACT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.74, ACT is valued at the same level.
Industry RankSector Rank
PE 26.33
Fwd PE 22.49
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ACT's Enterprise Value to EBITDA is on the same level as the industry average.
64.71% of the companies in the same industry are more expensive than ACT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.02
EV/EBITDA 14.29
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ACT may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 16.33% in the coming years.
PEG (NY)1.84
PEG (5Y)1.07
EPS Next 2Y13.05%
EPS Next 3Y16.33%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.33%, ACT has a reasonable but not impressive dividend return.
ACT's Dividend Yield is comparable with the industry average which is at 3.08.
Compared to an average S&P500 Dividend Yield of 2.37, ACT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACT pays out 22.58% of its income as dividend. This is a sustainable payout ratio.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.58%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (7/8/2025, 2:08:46 PM)

146.4

-1.6 (-1.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-30 2025-07-30
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners40.2%
Ins Owner ChangeN/A
Market Cap1.49B
Analysts81.82
Price Target121.21 (-17.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP22.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.56%
PT rev (3m)14.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.58%
Valuation
Industry RankSector Rank
PE 26.33
Fwd PE 22.49
P/S 2.69
P/FCF 24.02
P/OCF 14.17
P/B 7.25
P/tB 7.38
EV/EBITDA 14.29
EPS(TTM)5.56
EY3.8%
EPS(NY)6.51
Fwd EY4.45%
FCF(TTM)6.09
FCFY4.16%
OCF(TTM)10.33
OCFY7.06%
SpS54.44
BVpS20.19
TBVpS19.83
PEG (NY)1.84
PEG (5Y)1.07
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROCE 20.74%
ROIC 14.95%
ROICexc 17.85%
ROICexgc 18.06%
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
FCFM 11.2%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Debt/EBITDA 0.41
Cap/Depr 163.77%
Cap/Sales 7.78%
Interest Coverage 33.75
Cash Conversion 100.34%
Profit Quality 114.74%
Current Ratio 2.48
Quick Ratio 1.52
Altman-Z 5.6
F-Score7
WACC7.04%
ROIC/WACC2.12
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%
EBIT growth 1Y36.94%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y19.06%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y44.69%
OCF growth 3Y34.7%
OCF growth 5Y19.23%